drug
REGADENOSON
updated 3mo agoby APOTEX
community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying REGADENOSON
- N/AThe MATCH Investigation: CT Myocardial Perfusion and CT-FFR vs PET MPI
- phase2A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients
- —Use of Stress-CMR Using Regadenoson and GE-267 in Adult Patients with Known or Suspected Coronary Artery Disease
- phase1Regadenoson R-T Perfusion Imaging Trial
- phase2A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
- phase3Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
- phase3Regadenoson Real Time Perfusion Imaging Trial-Optison
- phase4Accuracy of an Echo-Stress Protocol Using Regadenoson With Speckle Tracking
Patent cliff
source: FDA Orange Bookfirst barrier falls
Feb 2, 2027
162 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (2)
- Feb 2, 2027compositionUS 8106183162d
- Feb 2, 2027formulationUS RE47301162d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 17m ago
Found something off?
comments(0)
5-min edit window · permanent after that